← Leaderboards
Michael Clare-Salzler
University Of Florida
$6,522,781
Attributed
$6,522,781
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $891.4K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$6,522,781 · 7
By mechanism
P01$5,021,787 · 5
R33$1,065,869 · 1
R21$435,125 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Mark A Atkinson$38,540,675
- Lyle L Moldawer$27,709,476
- Clayton E Mathews$19,414,489
- John M Petitto$4,830,883
- Zhiwei Xu$530,736
Others in their field
Top investigators on “Immune Function”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$339,809,082
- Lawrence Corey · Fred Hutchinson Cancer Center$238,174,530
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$232,589,547
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Daniel R Kuritzkes · Brigham And Women'S Hospital$114,040,879
- Judith S. Currier · University Of California Los Angeles$110,962,481
Research focus
Immune FunctionCellsProgramsInsulin-Dependent Diabetes MellitusDendritic CellsResponseMacrophageImmunePreventAutoimmunityPathogenesisCell MaturationDefectPredispositionAutoantibodiesHuman SubjectFrozen SectionsCellular BiologyEnvironmentInnovationGenesImmunogeneticsGeneticImmune System
Grant awards (26)
Interferon a/b in Type 1 Diabetes Pathogenesis$393,421
P01 · FY2017 · AI · contact PI
Biorepository and Pathology Core$227,174
P01 · FY2017 · AI · contact PI
Interferon a/b in Type 1 Diabetes Pathogenesis$501,928
P01 · FY2016 · AI · contact PI
Biorepository and Pathology Core$389,466
P01 · FY2016 · AI · contact PI
Interferon a/b in Type 1 Diabetes Pathogenesis$394,172
P01 · FY2015 · AI · contact PI
Biorepository and Pathology Core$188,556
P01 · FY2015 · AI · contact PI
Interferon a/b in Type 1 Diabetes Pathogenesis$415,440
P01 · FY2014 · AI · contact PI
Biorepository and Pathology Core$188,348
P01 · FY2014 · AI · contact PI
Interferon a/b in Type 1 Diabetes Pathogenesis$388,342
P01 · FY2013 · AI · contact PI
Biorepository and Pathology Core$176,062
P01 · FY2013 · AI · contact PI
Interferon a/b in Type 1 Diabetes Pathogenesis$280,798
P01 · FY2011 · AI · contact PI
Interferon a/b in Type 1 Diabetes Pathogenesis$286,084
P01 · FY2010 · AI · contact PI
Interferon a/b in Type 1 Diabetes Pathogenesis$287,948
P01 · FY2009 · AI · contact PI
Interferon a/b in Type 1 Diabetes Pathogenesis$265,393
P01 · FY2008 · AI · contact PI
Dendritic Cells and the Prevention of Type 1 Diabetes$342,611
R33 · FY2007 · DK · contact PI
Interferon a/b in Type 1 Diabetes Pathogenesis$272,345
P01 · FY2007 · AI · contact PI
Dendritic Cells and the Prevention of Type 1 Diabetes$347,057
R33 · FY2006 · DK · contact PI
Dendritic Cells and the Prevention of Type 1 Diabetes$376,201
R33 · FY2005 · DK
Dendritic Cells and the Prevention of Type 1 Diabetes$217,625
R21 · FY2003 · DK
Dendritic Cells and the Prevention of Type 1 Diabetes$217,500
R21 · FY2002 · DK
CORE--MOUSE FACILITY$0
P01 · FY2002 · AI
PGS-2 IN THE PATHOGENESIS OF IDDM$0
P01 · FY2002 · AI
CORE--MOUSE FACILITY$0
P01 · FY2001 · AI
PGS-2 IN THE PATHOGENESIS OF IDDM$0
P01 · FY2001 · AI
CORE--MOUSE FACILITY$183,155
P01 · FY2000 · AI
PGS-2 IN THE PATHOGENESIS OF IDD$183,155
P01 · FY2000 · AI